TR199700508A2 - Orto-ikame edilmi� benzoilguanidin'leri, bunlar�n imal edilmesine mahsus usul, bunlar�n ila� ya da diyagnoz maddesi olarak kullan�lmalar� ve ayr�ca bunlar� ihtiva eden ila�lar. - Google Patents
Orto-ikame edilmi� benzoilguanidin'leri, bunlar�n imal edilmesine mahsus usul, bunlar�n ila� ya da diyagnoz maddesi olarak kullan�lmalar� ve ayr�ca bunlar� ihtiva eden ila�lar.Info
- Publication number
- TR199700508A2 TR199700508A2 TR97/00508A TR9700508A TR199700508A2 TR 199700508 A2 TR199700508 A2 TR 199700508A2 TR 97/00508 A TR97/00508 A TR 97/00508A TR 9700508 A TR9700508 A TR 9700508A TR 199700508 A2 TR199700508 A2 TR 199700508A2
- Authority
- TR
- Turkey
- Prior art keywords
- ischemic
- ortho
- medicine
- manufacture
- well
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 3
- 229940079593 drug Drugs 0.000 title abstract 2
- AJDQRQQNNLZLPM-UHFFFAOYSA-N n-(diaminomethylidene)benzamide Chemical class NC(N)=NC(=O)C1=CC=CC=C1 AJDQRQQNNLZLPM-UHFFFAOYSA-N 0.000 title abstract 2
- 229940039227 diagnostic agent Drugs 0.000 title 1
- 239000000032 diagnostic agent Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 229940088679 drug related substance Drugs 0.000 abstract 3
- 230000000302 ischemic effect Effects 0.000 abstract 3
- 230000015572 biosynthetic process Effects 0.000 abstract 2
- 230000006378 damage Effects 0.000 abstract 2
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 1
- 230000009692 acute damage Effects 0.000 abstract 1
- 239000003416 antiarrhythmic agent Substances 0.000 abstract 1
- 206010003119 arrhythmia Diseases 0.000 abstract 1
- 230000003293 cardioprotective effect Effects 0.000 abstract 1
- 229920002678 cellulose Polymers 0.000 abstract 1
- 239000001913 cellulose Substances 0.000 abstract 1
- 230000009693 chronic damage Effects 0.000 abstract 1
- 230000003449 preventive effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19624178A DE19624178A1 (de) | 1996-06-18 | 1996-06-18 | Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR199700508A2 true TR199700508A2 (xx) | 1998-01-21 |
Family
ID=7797197
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR97/00508A TR199700508A2 (xx) | 1996-06-18 | 1997-06-16 | Orto-ikame edilmi� benzoilguanidin'leri, bunlar�n imal edilmesine mahsus usul, bunlar�n ila� ya da diyagnoz maddesi olarak kullan�lmalar� ve ayr�ca bunlar� ihtiva eden ila�lar. |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US6001881A (enExample) |
| EP (1) | EP0814077B1 (enExample) |
| JP (1) | JP3977897B2 (enExample) |
| KR (1) | KR100498799B1 (enExample) |
| CN (1) | CN1064676C (enExample) |
| AR (1) | AR012536A1 (enExample) |
| AT (1) | ATE191469T1 (enExample) |
| AU (1) | AU711734B2 (enExample) |
| BR (1) | BR9703617A (enExample) |
| CA (1) | CA2207886A1 (enExample) |
| CZ (1) | CZ291848B6 (enExample) |
| DE (2) | DE19624178A1 (enExample) |
| DK (1) | DK0814077T3 (enExample) |
| ES (1) | ES2146049T3 (enExample) |
| GR (1) | GR3033299T3 (enExample) |
| HR (1) | HRP970332B1 (enExample) |
| HU (1) | HUP9701057A3 (enExample) |
| ID (1) | ID17321A (enExample) |
| IL (1) | IL121085A0 (enExample) |
| MX (1) | MX9704486A (enExample) |
| MY (1) | MY117304A (enExample) |
| NO (1) | NO307928B1 (enExample) |
| NZ (1) | NZ328100A (enExample) |
| PL (1) | PL185756B1 (enExample) |
| PT (1) | PT814077E (enExample) |
| RU (1) | RU2193025C2 (enExample) |
| SI (1) | SI0814077T1 (enExample) |
| SK (1) | SK282351B6 (enExample) |
| TR (1) | TR199700508A2 (enExample) |
| TW (1) | TW374759B (enExample) |
| ZA (1) | ZA975312B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19608161A1 (de) * | 1996-03-04 | 1997-09-11 | Hoechst Ag | Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE19713427A1 (de) * | 1997-04-01 | 1998-10-08 | Hoechst Ag | Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE10001879A1 (de) * | 2000-01-19 | 2001-07-19 | Aventis Pharma Gmbh | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| US6641811B1 (en) * | 2000-02-10 | 2003-11-04 | Cornell Research Foundation, Inc. | Use of angiotensin II inhibitors to prevent malignancies associated with immunosuppression |
| US7828840B2 (en) * | 2007-11-15 | 2010-11-09 | Med Institute, Inc. | Medical devices and methods for local delivery of angiotensin II type 2 receptor antagonists |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4318658A1 (de) * | 1993-06-04 | 1994-12-08 | Hoechst Ag | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE4318756A1 (de) * | 1993-06-05 | 1994-12-08 | Hoechst Ag | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE4328869A1 (de) * | 1993-08-27 | 1995-03-02 | Hoechst Ag | Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE4430213A1 (de) * | 1994-08-28 | 1996-02-29 | Merck Patent Gmbh | Arylbenzoylguanidine |
| DE4430861A1 (de) * | 1994-08-31 | 1996-03-07 | Merck Patent Gmbh | Heterocyclyl-benzoylguanidine |
| DE4430916A1 (de) * | 1994-08-31 | 1996-03-07 | Merck Patent Gmbh | Alkyl-benzoylguanidin-Derivate |
| DE19608162A1 (de) * | 1996-03-04 | 1997-09-11 | Hoechst Ag | Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
-
1996
- 1996-06-18 DE DE19624178A patent/DE19624178A1/de not_active Withdrawn
-
1997
- 1997-06-03 PL PL97320326A patent/PL185756B1/pl not_active IP Right Cessation
- 1997-06-04 US US08/868,750 patent/US6001881A/en not_active Expired - Lifetime
- 1997-06-12 EP EP97109546A patent/EP0814077B1/de not_active Expired - Lifetime
- 1997-06-12 DK DK97109546T patent/DK0814077T3/da active
- 1997-06-12 PT PT97109546T patent/PT814077E/pt unknown
- 1997-06-12 SI SI9730060T patent/SI0814077T1/xx unknown
- 1997-06-12 ES ES97109546T patent/ES2146049T3/es not_active Expired - Lifetime
- 1997-06-12 DE DE59701388T patent/DE59701388D1/de not_active Expired - Lifetime
- 1997-06-12 AT AT97109546T patent/ATE191469T1/de not_active IP Right Cessation
- 1997-06-13 AR ARP970102605A patent/AR012536A1/es unknown
- 1997-06-16 IL IL12108597A patent/IL121085A0/xx not_active IP Right Cessation
- 1997-06-16 AU AU24942/97A patent/AU711734B2/en not_active Ceased
- 1997-06-16 TR TR97/00508A patent/TR199700508A2/xx unknown
- 1997-06-16 SK SK766-97A patent/SK282351B6/sk unknown
- 1997-06-16 TW TW086108285A patent/TW374759B/zh active
- 1997-06-16 ID IDP972057A patent/ID17321A/id unknown
- 1997-06-16 MY MYPI97002694A patent/MY117304A/en unknown
- 1997-06-16 CN CN97113806A patent/CN1064676C/zh not_active Expired - Fee Related
- 1997-06-16 NZ NZ328100A patent/NZ328100A/en unknown
- 1997-06-17 ZA ZA9705312A patent/ZA975312B/xx unknown
- 1997-06-17 HR HR19624178.2 patent/HRP970332B1/xx not_active IP Right Cessation
- 1997-06-17 CZ CZ19971887A patent/CZ291848B6/cs not_active IP Right Cessation
- 1997-06-17 MX MX9704486A patent/MX9704486A/es not_active IP Right Cessation
- 1997-06-17 JP JP15938297A patent/JP3977897B2/ja not_active Expired - Fee Related
- 1997-06-17 HU HU9701057A patent/HUP9701057A3/hu unknown
- 1997-06-17 RU RU97109528/04A patent/RU2193025C2/ru not_active IP Right Cessation
- 1997-06-17 CA CA002207886A patent/CA2207886A1/en not_active Abandoned
- 1997-06-17 NO NO972793A patent/NO307928B1/no unknown
- 1997-06-18 BR BR9703617A patent/BR9703617A/pt not_active Application Discontinuation
- 1997-06-18 KR KR1019970025282A patent/KR100498799B1/ko not_active Expired - Fee Related
-
2000
- 2000-04-21 GR GR20000400981T patent/GR3033299T3/el not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2186380A1 (en) | Novel carbamates and ureas as modifiers of multi-drug resistance | |
| DE69715888D1 (de) | Pyridylalken- und pyridylalkin-säureamide als cytostatika und immunosuppressive arzneimittel | |
| ATE31625T1 (de) | Pharmazeutisches mittel zur behandlung des diabetes mellitus. | |
| GR1001503B (el) | Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών. | |
| DE69725293D1 (de) | N-(2 oxoacetyl oder sulphonyl)-pyrrolidine/piperidine-2-carbonsäurederivate mit verbesserter multi-drug resistenz aktivität | |
| DK130883D0 (da) | Fremgangsmade til fremstilling af terapeutiske eller diagnostiske praeparater | |
| FR2392971A1 (fr) | Derives de l'acide prostanoique, leur preparation et medicament contenant ces substances | |
| DK0934309T3 (da) | Nye pyridylalkansyreamider som cytostatiske og immunosuppressive midler | |
| BR9713921A (pt) | Composto, composição farmacêutica, processo para tógico capaz de ser modulado através da inibição do fator xa | |
| DK0825197T3 (da) | Nye 6-hydroxy- og 6-oxo-androstanderivater, der er aktive i forhold til det cardiovaskulære system, og farmaceutiske præpar | |
| BR9705660A (pt) | 3-amidocromanilsulfonil (tio) uréias, processos para a sua preparação, seu uso, e preparações farmacêuticas compreendendo-as. | |
| TR199700453A2 (xx) | Orto-ikame edilmi� benzoilguanidin'ler, bunlar�n imal edilmesine mahsus usul, bunlar�n ila� ya da diyagnostik madde olarak kullan�lmalar� ve bunlar� ihtive eden ila�. | |
| NO961521D0 (no) | Antiarytmiske og kardiobeskyttende substituerte indenoylguanidiner | |
| ATE2423T1 (de) | 1-acyloxyphenyl-1,2-diphenylalken-derivate, verfahren zu deren herstellung und eine diese derivate enthaltende pharmazeutische zusammensetzung. | |
| CA2211982A1 (en) | Substituted indanylidineacetylguanidines, process for their preparation,their use as medicaments or diagnostic and medicaments containing them | |
| FR2381781A1 (fr) | Derives de la guanine et medicament contenant ces substances | |
| FR2376661A1 (fr) | Medicaments anthelminthiques renfermant comme substances actives des anilinomethylene-malononitriles | |
| TR199700423A2 (xx) | Bis-orto ikame edilmi� benzoilguanidin'ler, bunlar�n imal edilmesine mahsus usul, bunlar�n ila� ya da diyagnostik madde olarak kullan�lmalar� ve bunlar� ihtiva eden ila�lar. | |
| BR9803974A (pt) | Cromanos substituìdos por sulfonamida, processos para a sua preparação, seu emprego como medicamento e preparados farmacêuticos contendo os mesmos | |
| ATE2746T1 (de) | Piperidinderivate von 4,5-dialkyl-3-hydroxypyrrol-2-carbons[ureestern, ihre herstellung und diese enthaltende pharmazeutische zubereitungen. | |
| MX9704486A (es) | Benzoil-guanidinas sustituidas en orto, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento que las contiene. | |
| RU93000004A (ru) | Вещество для лечения подкожной фибрасаркомы и способ его получения | |
| IE43338L (en) | Pharmaceutical composition | |
| AR004331A1 (es) | Diguanidinas de acidos bencenodicarboxilicos sustituidas, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico asicomo medicamento que las contiene. | |
| KR910021244A (ko) | 당뇨병성 괴저 치료제 |